CVS Caremark Ahead of Earnings

Published on Tuesday, 07 February 2012 11:33 Written by Danny Miller

New York, February 7^th (TradersHuddle.com) – CVS Caremark (NYSE: CVS) was falling 0.32% to $43.13.ahead of the company reporting its earnings before the opening bell tomorrow.

On average analysts expect earnings of $0.89 per share on revenues of $28.12 billion. Last quarter the company posted a 2.9% upside surprise, as it earned $0.70 per share. The lowest earnings estimate is $0.87 per share, while highest earnings estimate is $0.92 per share.

CVS, the retail and pharmacy services company, has been trading near its 52-week high of $43.98. Yesterday, two CVS Pharmacies in Florida were caught up in a DEA prescription drug probe, with regulators banning the stores from dispensing controlled medicines, while news that the deal for Express Scripts (NASDAQ: ESRX) to buy Medco Health Solutions (NYSE: MHS) might be seeing increased regulatory scrutiny amid complaints from a trade group representing grocery chains.